Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shijiazhuang Xingbai Pharma Receives $18 Million Investment from Infinity

publication date: Mar 1, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shijiazhuang Xingbai Pharmaceutical Company of Hebei, a maker of biological pesticides, received a private equity investment of 120 million RMB ($18.3 million) from Israel-based Infinity. The financing is meant to increase Shijiazhuang Xingbai’s biotech capabilities, as the company makes plans for an IPO in the A-share market in three years. More details....

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...